22 results
424B3
RGBP
Regen BioPharma Inc
19 Mar 14
Prospectus supplement
12:00am
PERSONS 51
CORPORATE GOVERNANCE 52
SUMMARY COMPENSATION TABLES 53
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 60
AVAILABLE … , our Chairman and Chief Executive Officer, serves as Chairman and Chief Executive Officer of Entest BioMedical, Inc.
CORPORATE GOVERNANCE
Code
10-K
2014 FY
RGBP
Regen BioPharma Inc
18 Dec 14
Annual report
12:00am
control over financial reporting.
Item 10. Directors, Executive Officers and Corporate Governance
David R. Koos has served as Chairman of the Board
424B3
RGBP
Regen BioPharma Inc
20 Nov 23
Prospectus supplement
9:38am
over financial reporting.
Item 10. Directors, Executive Officers and Corporate Governance
Management and Directors:
David R. Koos has served
424B3
8igis noxj9bes
15 May 23
Prospectus supplement
10:25am
424B3
bilue16z
2 Oct 23
Prospectus supplement
1:42pm